Regenerative Medicine in Organ and Tissue Transplantation: Shortly and Practically Achievable?

摘要: Since the beginning of organ/tissue transplantation, therapeutic modality choice in end-stage organ failure, shortage has been main problem transplantation medicine. Given so far unsolved obstacle, all hope-raising procedures to possibly tackle this long-lasting can draw attentions. In context, “regenerative medicine” sounds be more promising compared other approaches. To consider huge impact hematopoietic stem cell on treatment some congenital or acquired hematological metabolic disorders and advances produce tissue engineered materials one hand, take aspects emerging costly interdisciplinary field research into consideration, inevitably makes reality unchanged, particular countries with low middle income, that allograft (from deceased living donors) will remain for years as irreplaceable source transplantation.